Acquisition Expands Reach in Latin America
Abbott products impact the lives of millions of people all around the world. Recently, Abbott announced its plans to further expand in a number of fast-growing Latin American markets through the acquisition of CFR Pharmaceuticals.
Headquartered in Santiago, Chile, CFR Pharmaceuticals participates in 15 Latin American countries. Its product portfolio is well aligned with Abbott's branded generic product offerings, specifically in the areas of women's health, central nervous system, cardiovascular and respiratory diseases. The addition of CFR will provide the opportunity to expand each company's portfolio across Latin America, addressing the health needs of even more people.
In addition to leading products and a robust pipeline, the acquisition adds a number of talented employees, and R&D and manufacturing facilities in Chile, Colombia, Peru and Argentina.
To learn more about the acquisition, which is scheduled to close in the third quarter of this year, click here.